Clinical Trial Update: To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate whether PF-04531083 affects blood levels of simvastatin and its primary acid metabolite when the two medications are co-administered, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• PF-04531083 (PF-04531083)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Pfizer | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED